Founded: 2012
Partnered: 2018
Sector: Advanced Manufacturing, Medical Devices
Industry: Orthopaedics
Stage: Seed Incubation
Market size: R4 million
Team: Dr. George Vicatos
ATTRI Orthopaedics, a South African company registered in 2012, derived its name from the acronym of Advanced Tumour and Trauma Reconstruction Implants. It excels in the design of orthopaedic implants destined exclusively for people who have suffered loss of bone tissue due to surgery.
The company is based in Cape Town and is linked with research institutes, manufacturing enterprises and specialist surgeons across the country.
Value Proposition
ATTRI Orthopaedics makes customised orthopaedic implants. Modern extendable implants allow for non-invasive extension to maintain limb length in skeletally immature children after bone loss due to cancer, trauma or skeletal disease; but devices contain ferromagnetic materials which are incompatible with normal diagnostic imaging techniques, and require physician facilitated extensions.
ATTRI has designed a unique, extendable titanium implant which contains no ferromagnetic materials and is capable of precise extensions comparable to natural bone growth, while permitting future monitoring of soft tissues by MRI or CT scanning in the case of tumour recurrence. It is controlled by a light-weight external device which transmits power to a subcutaneous coil via inductive coupling.
The device hardware is ready, with prelim designs for the electronics – seed funding is sought to finalise electronics and software, and to build two functional implants ready for use by specialist surgeons.
